Without prejudice to the conclusion that terbuthylazine should be approved, it is, in particular, appropriate to require further confirmatory information.
Recital 9, Commission Implementing Regulation (EU) No 820/2011 of 16 August 2011 approving the acti…
In forcesince 16 Aug 2011